Results 1 to 10 of about 14,620 (116)

Infections after high-voltage cardiac implantable electronic device replacements [PDF]

Heart Rhythm O2
Background: Device infection is the most worrisome complication after replacement of cardiac implantable electronic devices, with the utmost risk among patients with replacement of a high-voltage device.
Rasmus Langhoff, BM, Amar Taha, MD, PhD, Peter Raivio, MD, PhD, Juha Suhonen, MD, PhD, Pekka Raatikainen, MD, PhD, FHRS, Jarkko Karvonen, MD, PhD, Andreas Martinsson, MD, PhD, Markus Sane, MD, PhD   +7 more
doaj   +2 more sources

Use of Taurolidine in a Patient With a Cardiac Implantable Electronic Device Protrusion

JACC: Case Reports, 2023
We report the successful salvage of cardiac implantable electronic device pulse generator protrusion sealed by the surrounding skin in a frail patient presenting 5 months after the last surgical revision. (Level of Difficulty: Advanced.)
Marcello Giudice, MD, Bruna Catuzzo, MD, Nicola Berlier, MD, Ernest W. Lau, MD, Hendrik Bonnemeier, MD, PHD, Ojan Assadian, MD, PHD, Benito Baldauf, MD, Stefan Borov, MD, Paolo Scacciatella, MD   +8 more
doaj   +3 more sources

Prevotella bivia cardiac implantable electronic device related endocarditis

IDCases, 2022
Cases of Gram-negative, anaerobic rod bacteremia and endocarditis have been increasingly recognized in recent years. This increase has been primarily observed in patients at risk for polymicrobial infections, such as those who use injection drugs and ...
Benjamin Fogelson, James Livesay, Michael Rohrer, Megan Edwards, Jeffrey B. Hirsh   +4 more
doaj   +1 more source

Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta‐analysis

Journal of Arrhythmia, 2021
Introduction  Several studies have shown an inconsistent relationship between postimplantation pocket hematoma and cardiac implantable electronic device (CIED) infection.
Jakrin Kewcharoen, Chanavuth Kanitsoraphan, Sittinun Thangjui, Thiratest Leesutipornchai, Sakditad Saowapa, Apichai Pokawattana, Leenhapong Navaravong   +6 more
doaj   +1 more source

Interference of cardiac implantable electronic devices and computed tomography imaging in the current era with a phantom model

Journal of Arrhythmia, 2023
Introduction Cardiac implantable electronic devices are used in patients with cardiac rhythm disorders. Computed tomography irradiation is not prohibited for patients with cardiac implantable electronic devices, despite adverse events being reported ...
Akihito Ideishi, Kenichiro Yamagata, Tatsuya Nishii, Hideto Miyanooi, Yuichiro Miyazaki, Akinori Wakamiya, Keiko Shimamoto, Nobuhiko Ueda, Kenzaburo Nakajima, Mitsuru Wada, Tsukasa Kamakura, Kohei Ishibashi, Yuko Inoue, Koji Miyamoto, Takashi Noda, Satoshi Nagase, Takeshi Aiba, Kengo Kusano   +17 more
doaj   +1 more source

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Among patients with an implantable cardioverter‐defibrillator, a high prevalence of atrial fibrillation (AF) is present. Identification of AF predictors in this patient group is of clinical importance to initiate appropriate preventive ...
Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Nikki van Pouderoijen, Judith Krabbenborg, Mark J. Mulder, Mischa T. Rijnierse, Pranav Bhagirath, Lourens F. H. J. Robbers, Albert C. van Rossum, Vokko P. van Halm, Marco J. W. Götte, Cornelis P. Allaart   +11 more
doaj   +1 more source

Real‐World Disparities in Remote Follow‐Up of Cardiac Implantable Electronic Devices and Impact of the COVID‐19 Pandemic: A Single‐Center Experience

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Remote monitoring (RM) of cardiac implantable electronic devices has been shown to improve cardiovascular morbidity and mortality. To date, no studies have investigated disparities in use and delivery of RM.
H. Immo Lehmann, Krishan Sharma, Roma Bhatia, Theresa Mills, Joshua Lang, Guoping Li, Carl Andrews, Jay Cullivan, Jagmeet Singh, Theofanie Mela   +9 more
doaj   +1 more source

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator

JACC: Case Reports, 2023
Electromagnetic interference (EMI) between implantable left ventricular assist devices and cardiac implantable electronic devices has been observed. We demonstrated the first case of EMI between a percutaneous ventricular assist device and an implantable
Kosuke Takahari, MD, Takafumi Oka, MD, PhD, Takayuki Sekihara, MD, Kentaro Ozu, MD, Yasuhiro Akazawa, MD, PhD, Daisuke Nakamura, MD, Isamu Mizote, MD, PhD, Tomohito Ohtani, MD, PhD, Shungo Hikoso, MD, PhD, Yasushi Sakata, MD, PhD   +9 more
doaj   +1 more source

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

Tricuspid insufficiency after cardiac-implantable electronic device placement

Journal of Community Hospital Internal Medicine Perspectives, 2021
Objective Device-related estimates of incidence and significance of tricuspid regurgitation (TR) is mainly based on case reports and small observational studies.
Nismat Javed, Raafe Iqbal, Jahanzeb Malik, Ghazanfar Rana, Waheed Akhtar, Syed Muhammad Jawad Zaidi   +5 more
doaj   +1 more source